Navigation Links
DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Date:8/24/2007

NEW YORK, Aug. 24 /PRNewswire/ -- The DNA sequencing equipment market is expected to grow nearly 8% between 2006 and 2012, spiraling upward from $335 million to $528 million as competition intensifies and diversifies, according to DNA Sequencing Equipment and Service Markets, a new report by Kalorama Information.

The DNA sequencer market has been relatively stable for the last several years, with one dominant vendor and relatively few changes taking place in the products or technologies. However, the completion of several new products by 454 Life Sciences, Illumina/Solexa, and Applied Biosystems and the availability of vast amounts of annotated sequence data have allowed researchers to undertake a much wider range of experiments, fragmenting the market and moving products into additional segments with their own needs.

The emergence of several next-generation products with new applications, including gene expression analysis and epigenetics, in the next few years will also make a huge impact on the market. Growth is expected to be stimulated by the introduction of these new technologies and by researchers' essentially endless numbers of samples to analyze.

Although the new technologies will analyze much larger numbers of samples, researchers' demand will need to catch up to the increased capacity provided by the new purchases over the next couple of years, which will result in slower growth after the initial burst.

"The next two to three years will be a volatile time in the market, while the winners and losers get shaken out," said Justin Saeks, author of DNA Sequencing Equipment and Service Market. "Various aspects, including scientific, business, technology, and regulatory changes, could each turn out to play an unexpected role."

DNA Sequencing Equipment and Service Market covers DNA sequencing products used by the academia, government, pharmaceutical, and biotechnology industries. The report analyzes products in development and on the market, leading competitors, and current issues and trends. This report can be purchased directly from Kalorama Information by visiting https://www.kaloramainformation.com/DNA-Sequencing-Equipment-1430102/. It is also available at MarketResearch.com.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.

Contact:

Tom Ehart

MarketResearch.com

240-747-3014

tehart@marketresearch.com


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Purified Single-Stranded M13 DNA for Automated Sequencing
2. Automated Fluorescent-Tag Cycle Sequencing
3. Eppendorf Mastercycler ABI Big Dye Sequencing Protocol
4. END SEQUENCING
5. FULL LENGTH INSERT SEQUENCING
6. WHOLE GENOME SEQUENCING
7. SAGE & LONGSAGE SEQUENCING
8. SINGLE PASS SEQUENCING
9. QuickLane 24 - 48 Hour Sequencing
10. cDNA Sequencing & Finishing
11. Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Feb. 5, 2016  In the pharmaceutical industry the ... host of launch activities including the identification and engagement ... activity is especially high in the oncology therapeutic area ... Practices and the Role of Medical Affairs in Oncology ... on oncology therapies find better ways to utilize medical ...
(Date:2/5/2016)... 5, 2016 On Thursday, February 11, ... for community, health and disaster services, and the ... to enhance care coordination and service delivery for the ... need and to better connect service providers to the ... San Diego has handled more than ...
(Date:2/5/2016)... 2016 Amarantus BioScience Holdings, Inc. ... on developing products for Regenerative Medicine, Neurology and Orphan ... Designation (RPDD) from the US Food and Drug Administration ... was previously granted orphan drug designation (ODD) by the ... BioScience Holdings, Inc. (OTCQB: AMBS), a ...
(Date:2/5/2016)... 5, 2016 Australian-US drug discovery and development company, ... appointment of a new Chairman, Mr John O,Connor , ... immediately. James Garner , has also been ... former Acting CEO, Mr Iain Ross , will resume ... --> James Garner , has also been formally appointed ...
Breaking Biology Technology:
(Date:2/5/2016)... 5, 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ... "Global Facial Recognition Market 2016-2020" ... http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the addition of ... report to their offering. --> ... has announced the addition of the ...
(Date:2/4/2016)... 2016 The field of Human Microbiome ... most popular hubs of the biotechnology industry. While ... studies of human microbiota, have garnered a lot ... microbiome space has literally exploded in terms of ... report focuses on biomedical aspects of research, development, ...
(Date:2/3/2016)... 4, 2016 --> --> ... M (105.0), up 1,187% compared with fourth quarter of 2014. ... 517.6 M (loss: 30.0). Earnings per share increased to SEK ... 537.4 M (neg: 74.7). , --> ... to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
Breaking Biology News(10 mins):